Health & safety
UAE first to approve oral treatment for vitiligo
The Emirates Drug Establishment (EDE) has approved a new therapeutic indication for RINVOQ (upadacitinib) to treat non-segmental vitiligo in adults and adolescents aged...
The analysis — automated & source-checked
- Applies to
- Health & safety · UAE
- What to do
- No action required — monitor for further change.
Source
Reported by: Gulf Today 17 Aug 2026 Read the original ↗ More from Gulf Today →
Quick answers
Who reported this?
Gulf Today (UAE).
When was it announced?
17 Aug 2026.
Where can I read the original?
Read the original at Gulf Today: https://www.gulftoday.ae/news/2026/08/17/uae-becomes-first-country-in-the-world-to-approve-oral-treatment-for-non-segmental-vitiligo
Subscribe — free
Get the next change before it's a deadline
The whole front, every morning. Free.